Cosara Diagnostics announces regulatory approval obtained from (Central Drugs Standard Control Organisation) to manufacture and sell SARAGENE Dengue test kit. The tests are now available for sale.

SARAGENE Dengue test kit is an in vitro diagnostic test, based on Real-Time Polymerase Chain Reaction Technology. Test utilizes Co-Diagnostics' patented CoPrimers technology (Satterfield, 2014) (Poritz & Ririe, 2014).

It tests for the presence or absence of ribonucleic acid (RNA) of Dengue (Type 1, 2 4) in serum or plasma from patients suspected of dengue viral infection.

CoSara is a joint venture company of Synbiotics Limited, a wholly-owned subsidiary Ambalal Sarabhai Enterprises Limited and Co- Diagnostics Inc, USA.

CoSara has the exclusive manufacturing rights in India for the complete menu of Co-Diagnostics infectious disease molecular diagnostics kits, engineered using Co-Diagnostics’ proprietary design process and patented CoPrimer technology. CoSara was incorporated in 2017, and its 2,500 sq ft Good Manufacturing Practices (GMP) facility is one of the first of its kind in India for manufacturing in vitro diagnostics designated for clinical use.